Condition: Ureteral Stricture · Sponsor: Urotronic Inc.
The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
This description comes directly from the study's public registry record.
Steven M Principal Clinical Project Manager · 952-426-6079 · smadej@laborie.com
Reem Ennenga · rennenga@laborie.com
Always discuss trial participation with your own doctor first.
| University of California Irvine | Orange, California, United States | Recruiting |
| Orlando Health | Orlando, Florida, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Mount Sinai | New York, New York, United States | Recruiting |
| NYU Langone | New York, New York, United States | Recruiting |
| University of Texas Southwestern | Dallas, Texas, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07020520